ANALYSIS OF LONG-TERM RESULTS OF SURGICAL TREATMENT OF PATIENTS WITH MITRAL HEART DEFECTS AND ATRIOMEGALIA

Authors

DOI:

https://doi.org/10.11603/2414-4533.2025.3.15668

Keywords:

acquired heart defects, left atrial appendage plastic surgery, left atrial appendage resection, mitral valve prosthesis, long-term results

Abstract

The aim of the work: to study the risks of fatal cases in the long term after surgical treatment of patients with mitral heart defects and atriomegaly.

Materials and Methods. The study included 671 patients with mitral heart disease and left atriummegaly. Atriomegaly was considered as an increase in the linear size of the left atrium by more than 6.0 cm and its volume by more than 59.8 cm3/m2 according to echocardiography. All patients in the sample underwent surgical treatment of mitral valve disease at the Department of Surgical Treatment of Acquired Heart Defects of the State Institution "Amosov National Institute of Cardio-Vascular Surgery affiliated to National Academy of Medical Sciences of Ukraine". The study design was built depending on the surgical technique used and the volume of surgical intervention, according to which the patients in the sample were divided into two groups: the main and comparison groups. The main group (n=271) included patients who underwent mitral valve prosthesis and left atrial appendage resection. In patients in the comparison group (n=400), only surgical correction of mitral valve disease was performed. The material for analysis was data from primary medical records: medical history, operation protocols, and clinical and instrumental examination data. All patients of the study gave informed voluntary consent.

Results. In this study, hospital mortality was 2.2 % among all cases, in patients of the main group it was 1.8 %, and in the comparison group – 2.5 % (p>0.05). It was established that the frequency of fatal cases in patients of the sample in the long term was 5.8 %, in patients of the main group – 4.5 %, and in the comparison group – 6.7 % (p=0.015; χ2=5.93). It was found that patients who underwent left atrial plasty for atrial atrium megaly with resection of its appendage, in addition to surgical correction of mitral valve disease, had a reduced risk of mortality both in the hospital period (OR=1.35; 95 % CI: 0.45–4.0, RR=1.34; 95 % CI: 0.46–3.89, p>0.05) and in the period of observation of long-term results (OR=1.50; 95 % CI: 0.74–3.02, RR=1.46; 95 % CI: 0.75–2.85, p>0.05).

Conclusions. As a result of studying the long-term results of surgical treatment of the mitral valve in patients with atriomegaly, it was found that patients who underwent its correction and left atrial appendage resection with resection of its appendage have a lower frequency of hospital mortality and a 1.35-fold lower risk of its occurrence (OR=1.35; RR=1.34; p>0.05). Patients who underwent correction of mitral heart defect and left atrial appendage resection have a significantly lower frequency of fatal events in the long term after surgery (p=0.015; χ2=5.93) and a 1.5-fold lower risk of their occurrence, compared with patients who underwent only surgical correction of mitral heart defect (OR=1.50; RR=1.46; p>0.05).

Author Biographies

V. ZH. BОUKARIM, Amosov National Institute of Cardiovascular Surgery, Kyіv, Ukraine

Cardiovascular surgeon, junior research fellow of the Department of Surgical Treatment of Acquired Heart Defects

V. V. POPOV, Amosov National Institute of Cardiovascular Surgery, Kyіv, Ukraine

DSc (Medicine), Professor, Head of the Department of Surgical Treatment of Acquired Heart Defects

References

Douedi S, Douedi H. Mitral Regurgitation [Updated 2024 Apr 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan.- Available from: https://www.ncbi.nlm.nih.gov/books/NBK553135/.

Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Munoz DR, Rosenhek R, Sjogren S, Tornos P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep. 21; 38(36):2739-91.

Rudenko SA, Potashev SV, Hrubyak LM, Mazur OA, Hohayeva OK, Rudenko AV. Ishemichna mitralʹna rehurhitatsiya: ohlyad suchasnykh dokazovykh danykh pro ekhokardiohrafichnu diahnostyku, otsinyuvannya ta stratyfikatsiyu ryzyku [Ischemic mitral regurgitation: a review of current evidence on echocardiographic diagnosis, assessment and risk stratification]. Ukrayinsʹkyy zhurnal sertsevo-sudynnoyi khirurhiyi. 2019; 4(37): 9-16. DOI: 10.30702/ujcvs/19.3712/08009-016. Ukrainian. DOI: https://doi.org/10.30702/ujcvs/19.3712/08009-016

Apostolakis E, Shuhaiber JH. The surgical management of giant left atrium. Eur J Cardiothorac Surg. 2008 Feb.; 33(2):182-90. DOI: 10.1016/j.ejcts.2007.11.003. DOI: https://doi.org/10.1016/j.ejcts.2007.11.003

Fan X, Tang Y, Ma Y, Zhang B, Lu J, Han L, Chen Y. Mitral valve repair and concomitant maze procedure versus catheter ablation in the treatment of atrial functional mitral regurgitation. BMC Cardiovasc Disord. 2022 Dec. 12; 22(1):543. DOI: 10.1186/s12872-022-02972-4. DOI: https://doi.org/10.1186/s12872-022-02972-4

Minami Y, Haruki S, Yashiro B, Suzuki T, Ashihara K, Hagiwara N. Enlarged left atrium and sudden death risk in hypertrophic cardiomyopathy patients with or without atrial fibrillation. J Cardiol. 2016 Dec.; 68(6):478-84. DOI: 10.1016/j.jjcc.2016.01.006. DOI: https://doi.org/10.1016/j.jjcc.2016.01.006

Dragasis S, Vlachos K, Kariki O, Koskina S, Zygouri A, Patsiotis IG, Anastasakis A, Athanasopoulos G, Ritsatos K, Letsas K, Efremidis M. Atrial fibrillation in hypertrophic cardiomyopathy - A contemporary mini-review. Hellenic J Cardiol. 2022 Sep.-Oct.; 67:66-72. DOI: 10.1016/j.hjc.2022.05.002. DOI: https://doi.org/10.1016/j.hjc.2022.05.002

Arora S, Brown ZD, Sivaraj K, Hendrickson MJ, Mazzella AJ, Chang PP, Vaduganathan M, Qamar A, Gehi AK, Pandey A, Vavalle JP. The Relationship Between Atrial Fibrillation, Mitral Regurgitation, and Heart Failure Subtype: The ARIC Study. J Card Fail. 2022 Jun.; 28(6):883-92. DOI: 10.1016/j.cardfail.2021.10.015. DOI: https://doi.org/10.1016/j.cardfail.2021.10.015

Nicoli CD, O'Neal WT, Levitan EB, Singleton MJ, Judd SE, Howard G, Safford MM, Soliman EZ. Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction. Heart. 2022; 108(5):353-59. DOI: 10.1136/heartjnl-2021-319122. DOI: https://doi.org/10.1136/heartjnl-2021-319122

Liu XM, Wu H, Zhang WK, Xu ZW, Xu XF, Li WB, Meng X, Chen BT, Zhou QW, Zhou ZF. Long-term results of surgical treatment of aortic and mitral regurgitation with enlarged left ventricle. Int J Clin Exp Med. 2014 Mar. 15; 7(3):709-13.

Published

2025-10-23

How to Cite

BОUKARIM V. Z., & POPOV, V. V. (2025). ANALYSIS OF LONG-TERM RESULTS OF SURGICAL TREATMENT OF PATIENTS WITH MITRAL HEART DEFECTS AND ATRIOMEGALIA. Hospital Surgery. Journal Named by L.Ya. Kovalchuk, (3), 121–125. https://doi.org/10.11603/2414-4533.2025.3.15668

Issue

Section

EXPERIENCE OF WORK